BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas

Abstract

These results demonstrate that BRAF immunohistochemistry could serve as a useful addition to a marker panel for selecting intermediate thickness melanoma patients for SNB.